4-(1,1-dioxothiazinan-2-yl)-N-(4-methyl-3-quinolin-2-ylphenyl)benzenesulfonamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-2-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-5-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-(3-quinolin-2-ylphenyl)benzamide

C102H92N14O13S5 — CID 157422841

IUPAC4-(1,1-dioxothiazinan-2-yl)-N-(4-methyl-3-quinolin-2-ylphenyl)benzenesulfonamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-2-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-5-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-(3-quinolin-2-ylphenyl)benzamide
SMILESCc1ccc(NS(=O)(=O)c2ccc(N3CCCCS3(=O)=O)cc2)cc1-c1ccc2ccccc2n1.O=C(Nc1cccc(-c2ccc3ccccc3n2)c1)c1ccc(N2CCCCS2(=O)=O)cc1.O=C(Nc1cccc(-c2ccc3cnccc3n2)c1)c1ccc(N2CCCCS2(=O)=O)cc1.O=C(Nc1cccc(-c2nccc3ncccc23)c1)c1ccc(N2CCCCS2(=O)=O)cc1
InChIInChI=1S/C26H25N3O4S2.C26H23N3O3S.2C25H22N4O3S/c1-19-8-10-21(18-24(19)26-15-9-20-6-2-3-7-25(20)27-26)28-35(32,33)23-13-11-22(12-14-23)29-16-4-5-17-34(29,30)31;30-26(20-10-13-23(14-11-20)29-16-3-4-17-33(29,31)32)27-22-8-5-7-21(18-22)25-15-12-19-6-1-2-9-24(19)28-25;30-25(18-8-10-21(11-9-18)29-15-1-2-16-33(29,31)32)28-20-6-3-5-19(17-20)24-22-7-4-13-26-23(22)12-14-27-24;30-25(18-6-9-22(10-7-18)29-14-1-2-15-33(29,31)32)27-21-5-3-4-19(16-21)23-11-8-20-17-26-13-12-24(20)28-23/h2-3,6-15,18,28H,4-5,16-17H2,1H3;1-2,5-15,18H,3-4,16-17H2,(H,27,30);3-14,17H,1-2,15-16H2,(H,28,30);3-13,16-17H,1-2,14-15H2,(H,27,30)
InChIKeyBPPPDJSWAUVEGN-UHFFFAOYSA-N
MW1882.28 g/mol
LogP18.98
Rot. Bonds17

About 4-(1,1-dioxothiazinan-2-yl)-N-(4-methyl-3-quinolin-2-ylphenyl)benzenesulfonamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-2-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-5-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-(3-quinolin-2-ylphenyl)benzamide

4-(1,1-dioxothiazinan-2-yl)-N-(4-methyl-3-quinolin-2-ylphenyl)benzenesulfonamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-2-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-5-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-(3-quinolin-2-ylphenyl)benzamide (PubChem CID 157422841) has the molecular formula C102H92N14O13S5 and a molecular weight of 1882.28 g/mol. Its IUPAC name is 4-(1,1-dioxothiazinan-2-yl)-N-(4-methyl-3-quinolin-2-ylphenyl)benzenesulfonamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-2-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-5-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-(3-quinolin-2-ylphenyl)benzamide.

Molecular Properties

Compound Name4-(1,1-dioxothiazinan-2-yl)-N-(4-methyl-3-quinolin-2-ylphenyl)benzenesulfonamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-2-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-5-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-(3-quinolin-2-ylphenyl)benzamide
PubChem CID157422841
Molecular FormulaC102H92N14O13S5
Molecular Weight1882.28 g/mol
Exact Mass1880.56
IUPAC Name4-(1,1-dioxothiazinan-2-yl)-N-(4-methyl-3-quinolin-2-ylphenyl)benzenesulfonamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-2-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-5-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-(3-quinolin-2-ylphenyl)benzamide
SMILESCc1ccc(NS(=O)(=O)c2ccc(N3CCCCS3(=O)=O)cc2)cc1-c1ccc2ccccc2n1.O=C(Nc1cccc(-c2ccc3ccccc3n2)c1)c1ccc(N2CCCCS2(=O)=O)cc1.O=C(Nc1cccc(-c2ccc3cnccc3n2)c1)c1ccc(N2CCCCS2(=O)=O)cc1.O=C(Nc1cccc(-c2nccc3ncccc23)c1)c1ccc(N2CCCCS2(=O)=O)cc1
InChIInChI=1S/C26H25N3O4S2.C26H23N3O3S.2C25H22N4O3S/c1-19-8-10-21(18-24(19)26-15-9-20-6-2-3-7-25(20)27-26)28-35(32,33)23-13-11-22(12-14-23)29-16-4-5-17-34(29,30)31;30-26(20-10-13-23(14-11-20)29-16-3-4-17-33(29,31)32)27-22-8-5-7-21(18-22)25-15-12-19-6-1-2-9-24(19)28-25;30-25(18-8-10-21(11-9-18)29-15-1-2-16-33(29,31)32)28-20-6-3-5-19(17-20)24-22-7-4-13-26-23(22)12-14-27-24;30-25(18-6-9-22(10-7-18)29-14-1-2-15-33(29,31)32)27-21-5-3-4-19(16-21)23-11-8-20-17-26-13-12-24(20)28-23/h2-3,6-15,18,28H,4-5,16-17H2,1H3;1-2,5-15,18H,3-4,16-17H2,(H,27,30);3-14,17H,1-2,15-16H2,(H,28,30);3-13,16-17H,1-2,14-15H2,(H,27,30)
InChIKeyBPPPDJSWAUVEGN-UHFFFAOYSA-N
XLogP18.98
TPSA360.33 Ų
H-Bond Donors4
H-Bond Acceptors19
Rotatable Bonds17
Heavy Atoms134
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001882.28
LogP ≤ 518.98
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1019

Analyze 4-(1,1-dioxothiazinan-2-yl)-N-(4-methyl-3-quinolin-2-ylphenyl)benzenesulfonamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-2-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-5-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-(3-quinolin-2-ylphenyl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-(1,1-dioxothiazinan-2-yl)-N-(4-methyl-3-quinolin-2-ylphenyl)benzenesulfonamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-2-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-5-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-(3-quinolin-2-ylphenyl)benzamide?
The IUPAC name of 4-(1,1-dioxothiazinan-2-yl)-N-(4-methyl-3-quinolin-2-ylphenyl)benzenesulfonamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-2-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-5-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-(3-quinolin-2-ylphenyl)benzamide (CID 157422841) is 4-(1,1-dioxothiazinan-2-yl)-N-(4-methyl-3-quinolin-2-ylphenyl)benzenesulfonamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-2-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-5-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-(3-quinolin-2-ylphenyl)benzamide.
What is the SMILES notation for 4-(1,1-dioxothiazinan-2-yl)-N-(4-methyl-3-quinolin-2-ylphenyl)benzenesulfonamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-2-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-5-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-(3-quinolin-2-ylphenyl)benzamide?
The canonical SMILES for 4-(1,1-dioxothiazinan-2-yl)-N-(4-methyl-3-quinolin-2-ylphenyl)benzenesulfonamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-2-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-5-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-(3-quinolin-2-ylphenyl)benzamide is Cc1ccc(NS(=O)(=O)c2ccc(N3CCCCS3(=O)=O)cc2)cc1-c1ccc2ccccc2n1.O=C(Nc1cccc(-c2ccc3ccccc3n2)c1)c1ccc(N2CCCCS2(=O)=O)cc1.O=C(Nc1cccc(-c2ccc3cnccc3n2)c1)c1ccc(N2CCCCS2(=O)=O)cc1.O=C(Nc1cccc(-c2nccc3ncccc23)c1)c1ccc(N2CCCCS2(=O)=O)cc1.
What is the InChIKey of 4-(1,1-dioxothiazinan-2-yl)-N-(4-methyl-3-quinolin-2-ylphenyl)benzenesulfonamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-2-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-5-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-(3-quinolin-2-ylphenyl)benzamide?
The InChIKey is BPPPDJSWAUVEGN-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H25N3O4S2.C26H23N3O3S.2C25H22N4O3S/c1-19-8-10-21(18-24(19)26-15-9-20-6-2-3-7-25(20)27-26)28-35(32,33)23-13-11-22(12-14-23)29-16-4-5-17-34(29,30)31;30-26(20-10-13-23(14-11-20)29-16-3-4-17-33(29,31)32)27-22-8-5-7-21(18-22)25-15-12-19-6-1-2-9-24(19)28-25;30-25(18-8-10-21(11-9-18)29-15-1-2-16-33(29,31)32)28-20-6-3-5-19(17-20)24-22-7-4-13-26-23(22)12-14-27-24;30-25(18-6-9-22(10-7-18)29-14-1-2-15-33(29,31)32)27-21-5-3-4-19(16-21)23-11-8-20-17-26-13-12-24(20)28-23/h2-3,6-15,18,28H,4-5,16-17H2,1H3;1-2,5-15,18H,3-4,16-17H2,(H,27,30);3-14,17H,1-2,15-16H2,(H,28,30);3-13,16-17H,1-2,14-15H2,(H,27,30).
What are the key properties of 4-(1,1-dioxothiazinan-2-yl)-N-(4-methyl-3-quinolin-2-ylphenyl)benzenesulfonamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-2-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-5-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-(3-quinolin-2-ylphenyl)benzamide?
4-(1,1-dioxothiazinan-2-yl)-N-(4-methyl-3-quinolin-2-ylphenyl)benzenesulfonamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-2-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-5-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-(3-quinolin-2-ylphenyl)benzamide has a molecular weight of 1882.28 g/mol, XLogP of 18.98, 17 rotatable bonds, 4 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(1,1-dioxothiazinan-2-yl)-N-(4-methyl-3-quinolin-2-ylphenyl)benzenesulfonamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-2-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-[3-(1,6-naphthyridin-5-yl)phenyl]benzamide;4-(1,1-dioxothiazinan-2-yl)-N-(3-quinolin-2-ylphenyl)benzamide is sourced from PubChem (CID 157422841), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).